Accurate detection of ER/PR positive nuclei in the spatial context of surrounding tissue structures is a prerequisite for a comprehensive assessment of hormone receptor signaling both in breast cancer and normal tissues. This evidence concerns the gene ESR1 and breast carcinoma.